Investing > Timing the market
500M for the end of fiscal year 2019
1B$ for the end of fiscal year 2020 (same target as Canopy Growth)
Both targets exclude CC Pharma amazing revenue stream
Aurora and Canopy have their growth potential priced in, not Aphria.
You can double up your money if you hold this stock for 1 year , not Aurora or Canopy.
Act like a poor retail investor that doesn't wanna be patient and want big returns overnight
and you will stay poor.
Fundamentals > Strangers thinking Aphria share is a lottery ticket